论文信息 - Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. - 字舞流文

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

W. Gerald | T. Foster | C. Cordon-Cardo | A. Puzio-Kuter | M. Castillo-Martin | C. Abate-Shen | Yvonne Sun | X. Ouyang | Hui Gao | C. Kinkade | Jun Yan | Anna M. Puzio-Kuter